Literature DB >> 35733752

Nephrotic Syndrome Complications - New and Old. Part 1.

Ruxandra Mihaela Busuioc1, Gabriel Mircescu1.   

Abstract

Nephrotic syndrome is a rare condition with an incidence of 2-7 cases/100.000 children per year and three new cases/100.000 adults per year. It occurs as a result of severe alteration of the glomerular filtration barrier of various causes, allowing proteins, mostly albumin, to be lost in the urine. Nephrotic syndrome complications are driven by the magnitude of either proteinuria or hypoalbuminemia, or both. Their frequency and severity vary with proteinuria and serum albumin level. Besides albumin, many other proteins are lost in urine. Therefore, nephrotic patients could have low levels of binding proteins for ions, vitamins, hormones, lipoproteins, coagulation factors. The liver tries to counterbalance these losses and will increase the unselective synthesis of all types of proteins. All of these changes will have different clinical consequences. The present paper aims to discuss the pathophysiological mechanism and new therapeutic recommendations for nephrotic syndrome edema and thromboembolic complications.

Entities:  

Year:  2022        PMID: 35733752      PMCID: PMC9168581          DOI: 10.26574/maedica.2022.17.1.153

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  63 in total

1.  Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.

Authors:  Rajiv Agarwal; J Christopher Gorski; Kimberly Sundblad; D Craig Brater
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

2.  Clinical Pharmacology in Diuretic Use.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

3.  Protein C levels in nephrotic syndrome: use of a new enzyme-linked immunoadsorbent assay for protein C antigen.

Authors:  G A Soff; D A Sica; R A Marlar; H J Evans; G D Qureshi
Journal:  Am J Hematol       Date:  1986-05       Impact factor: 10.047

4.  Is tolvaptan indicated for refractory oedema in nephrotic syndrome?

Authors:  Eun-Sik Park; Youn-sung Huh; Gheun-Ho Kim
Journal:  Nephrology (Carlton)       Date:  2015-02       Impact factor: 2.506

5.  Nephrotic syndrome redux.

Authors:  Richard J Glassock; Fernando C Fervenza; Lee Hebert; J Stewart Cameron
Journal:  Nephrol Dial Transplant       Date:  2014-04-10       Impact factor: 5.992

Review 6.  The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.

Authors:  Melissa A Cadnapaphornchai; Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714

Review 7.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

8.  Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome.

Authors:  Gener Ismail; Bogdan Obrișcă; Roxana Jurubiță; Andreea Andronesi; Bogdan Sorohan; Mihai Hârza
Journal:  Medicina (Kaunas)       Date:  2020-05-19       Impact factor: 2.430

9.  The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy.

Authors:  Peimei Zou; Hang Li; Jianfang Cai; Chao Li; Zhenjie Chen; Xuewang Li
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

10.  Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome.

Authors:  Eduardo Molina-Jijon; Stéphanie Gambut; Camille Macé; Carmen Avila-Casado; Lionel C Clement
Journal:  Kidney Int       Date:  2020-08-01       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.